| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/27/2005 | EP1556477A2 Drying process |
| 07/27/2005 | EP1556404A2 Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof |
| 07/27/2005 | EP1556083A2 Methods for treating post-surgical pain by admisnistering a nerve growth factor antagonist and compositions containing the same |
| 07/27/2005 | EP1556082A1 Anti-cancer vaccines and high-dose cytokines as adjuvants |
| 07/27/2005 | EP1556081A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 07/27/2005 | EP1556071A2 Methods to prevent tumor recurrence by blockade of tgf-beta |
| 07/27/2005 | EP1556069A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 07/27/2005 | EP1144014B1 Composition and method for obtaining specific immunisation against one or more antigens using different recombinant vectors |
| 07/27/2005 | EP1077716B1 Preparation of a medicament for the treatment of gastroesophageal reflux disease |
| 07/27/2005 | EP1053018B1 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES |
| 07/27/2005 | EP0990000B1 Connective tissue growth factor-3 |
| 07/27/2005 | EP0920510B1 GnRH-LEUKOTOXIN CHIMERAS |
| 07/27/2005 | EP0682707B1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 07/27/2005 | CN1646703A Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 07/27/2005 | CN1646693A Enveloped microorganism |
| 07/27/2005 | CN1646692A Genetic products differentially expressed in tumors and use thereof |
| 07/27/2005 | CN1646684A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 07/27/2005 | CN1646567A Anti-idiotype anti-CEA antibody molecules and its use as cancer vaccine |
| 07/27/2005 | CN1646566A Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40 |
| 07/27/2005 | CN1646564A 修饰的因子Ⅷ Modification factor Ⅷ |
| 07/27/2005 | CN1646563A Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/27/2005 | CN1646560A Nucleotide sequence coding for a ToIC containing a heterologous amino acid sequence |
| 07/27/2005 | CN1646559A Immunological methods and compositions for the treatment of alzheimer's disease |
| 07/27/2005 | CN1646173A Microparticles comprising carbohydrate beads covalently linked with allergen |
| 07/27/2005 | CN1646163A Administration of agents for the treatment of inflammation |
| 07/27/2005 | CN1646162A Use of an inhibitor or antagonist against tissue factor |
| 07/27/2005 | CN1646161A Reagents and treatment methods for autoimmune diseases |
| 07/27/2005 | CN1646160A Anti-alpha V beta 6 antibodies |
| 07/27/2005 | CN1646159A Immunoadjuvant |
| 07/27/2005 | CN1646158A Modified vaccinia virus ankara for the vaccination of neonates |
| 07/27/2005 | CN1646157A Multiple and multivalent DNA vaccines in ovo |
| 07/27/2005 | CN1646156A Strategy for retroviral immunotherapy |
| 07/27/2005 | CN1646155A Cancer therapy |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646153A Active antiangiogenic therapy |
| 07/27/2005 | CN1646147A Method and composition for targeting of a systemically generated immune response to a specific organ or tissue |
| 07/27/2005 | CN1646020A Methods and composition for delivering nucleic acids and/or proteins to the respiratory system |
| 07/27/2005 | CN1645143A Method of detecting immune response |
| 07/27/2005 | CN1644686A High yielded strain of mammalia influenza virus, its recommbined strains and preparation and use thereof |
| 07/27/2005 | CN1644680A No mark gene deletion deoxidated mutant strain of wild Manhu bacteria and its use |
| 07/27/2005 | CN1212400C Method for obtaining transgenic rape chloroplast plant for producing foot-and-mouth disease vaccine |
| 07/27/2005 | CN1212399C Method for obtaining transgenic mountain lettuce chloroplast plant for producing foot-and-mouth disease vaccine |
| 07/27/2005 | CN1212155C CD 40 binding molecules and CTL peptides for treating tumors |
| 07/27/2005 | CN1212153C Immunologic adjuvant origniated from plants, and its preparing method and use |
| 07/27/2005 | CN1212152C Tumor necrosis factor antagonists and their use in endometriosis |
| 07/26/2005 | US6921809 Immunoglobulin conjugate comprising amino acid sequences from dihydrolipoamide dehydrogenase (P64K) for use as tool in immunodetection of heterologous protein expression; vaccine development |
| 07/26/2005 | US6921664 Telomerase |
| 07/26/2005 | US6921644 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders |
| 07/26/2005 | US6921543 Administering immunogenically effective amount of immunogen and an immunomodulatory effective amount of a lipid extract of Perna canaliculus or Mytilus edulis for modulating the immune response to an immunogen in a human or animal patient |
| 07/26/2005 | US6921537 Extracting with a polyoxyethylene detergent to deplete inner membranes, extracting remaining outer membranes with zwitterionic betaine dertergent to separate lipooligosaccharides from insoluble factions used for vaccines |
| 07/26/2005 | US6921536 Lawsonia intracellularis vaccine |
| 07/26/2005 | US6921535 Attenuated Bovine Respiratory Syncytial virus |
| 07/26/2005 | US6921534 Hepatitis B virus treatment |
| 07/26/2005 | US6921533 Method of using monoclonal antibodies against leukocyte adhesion receptor β-chain |
| 07/26/2005 | US6921528 Highly efficient delivery of a large therapeutic mass aerosol |
| 07/26/2005 | US6921527 Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery |
| 07/26/2005 | CA2269115C Monovalent antibody fragments |
| 07/26/2005 | CA2143823C Retro-, inverso - and retro-inverso synthetic peptide analogues |
| 07/26/2005 | CA2089552C Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof |
| 07/26/2005 | CA2076961C Igg-1 human monoclonal antibody reactive with an hiv-1 glycoprotein and method of use |
| 07/21/2005 | WO2005066333A1 Stabilizing compositions for recombinant viruses |
| 07/21/2005 | WO2005066204A2 Neutralizing epitope-based growth enhancing vaccine |
| 07/21/2005 | WO2005065718A2 Antitumour treatments with metxia-p450 and cyclophosphamide or 5t4 vaccine |
| 07/21/2005 | WO2005065711A2 Mammalian receptor proteins; related reagents and methods |
| 07/21/2005 | WO2005065710A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 07/21/2005 | WO2005065708A2 Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability |
| 07/21/2005 | WO2005065707A2 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof |
| 07/21/2005 | WO2005065678A1 Immunomodulatory combinations |
| 07/21/2005 | WO2005065418A2 Compositions and methods of use of targeting peptides for diagnosis and therapy |
| 07/21/2005 | WO2005065384A2 Electronic trading data integration and protection system |
| 07/21/2005 | WO2005065382A2 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof |
| 07/21/2005 | WO2005065121A2 Methods and compositions for the production of monoclonal antibodies |
| 07/21/2005 | WO2005065015A2 Neutralizing antibodies and methods of use thereof |
| 07/21/2005 | WO2005049786A3 Modulation of angiogenesis by bartonella henselae |
| 07/21/2005 | WO2005046722A3 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer |
| 07/21/2005 | WO2005042018A3 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 07/21/2005 | WO2005039630A3 Immunogenic compositions |
| 07/21/2005 | WO2005030251A8 Compositions and methods to accelerate hematologic recovery |
| 07/21/2005 | WO2005025618A3 Treatment of rheumatoid arthritis with cd99 antagonists |
| 07/21/2005 | WO2005012351A3 Novel functions for decay accelerating factor (daf) in inflammation |
| 07/21/2005 | WO2004091520A3 Methods and compositions for treating atherosclerosis |
| 07/21/2005 | WO2004024064A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | WO2004018648A3 Methods for treating patients and identifying therapeutics |
| 07/21/2005 | WO2003057160A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050159591 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050159588 Nucleotide sequences coding tumor-associated antigenic target polypeptides; diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 07/21/2005 | US20050159587 Extracellular junctional adhesion molecules |
| 07/21/2005 | US20050159435 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 07/21/2005 | US20050159425 Inducing tolerance to an antigen by administering to patient a prostaglandin or agonist thereof, a phosphodiesterase inhibitor, and antigen or a derivative thereof; suppressing immune system or an inflammatory response; for example, use of misoprostol and rolipram; antiinflammatory agents, antiallergens |
| 07/21/2005 | US20050159390 Treatment and prevention of HIV and other viral infections |
| 07/21/2005 | US20050159386 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 07/21/2005 | US20050159373 Novel polypeptides, and nucleic acids encoding the same |
| 07/21/2005 | US20050159357 Treatment of rheumatoid arthritis with soluble Fas-ligand cross-linkers |
| 07/21/2005 | US20050159336 Administering activated lymphocytes; promote nerve regeneration |
| 07/21/2005 | US20050159332 Ntb-a,a a surface molecule involved in natural killer cellss activity |
| 07/21/2005 | US20050158831 Using tumor necrosis factor superfamily polypeptides (TNFSF) as therapeutic agents in treatment of cell proliferative, inflammatory, autoimmune, cardiovascular and viral infection; tumor immunotherapy; wound healing agents |
| 07/21/2005 | US20050158828 Preparing immunoglobulin dimer for use in prevention and treatment of B cell lymphoma and chronic lymphocytic leukemia; immunotherapeutics |
| 07/21/2005 | US20050158778 Transcription factor for use in generating immoglobulin for prevention and treatment of fungal infection |
| 07/21/2005 | US20050158757 Methods for the early diagnosis of ovarian cancer |
| 07/21/2005 | US20050158753 Using presence of gastrointestinal system protein (CS141) as diagnostic indcator of gastrointestinal disorders; diagnosing colon and rectum cancer |